MGAT5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.735800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.942600E-01
Normal-vs-Stage2
2.190800E-01
Normal-vs-Stage3
2.345200E-01
Normal-vs-Stage4
8.893600E-01
Stage1-vs-Stage2
6.430000E-01
Stage1-vs-Stage3
4.277200E-01
Stage1-vs-Stage4
2.260000E-01
Stage2-vs-Stage3
2.766200E-01
Stage2-vs-Stage4
2.653400E-01
Stage3-vs-Stage4
1.297020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.444580E-01
Normal-vs-AfricanAmerican
9.372000E-01
Normal-vs-Asian
1.727570E-01
Caucasian-vs-AfricanAmerican
2.426400E-02
Caucasian-vs-Asian
4.335800E-01
AfricanAmerican-vs-Asian
5.921800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.164400E-01
Normal-vs-Female
5.294000E-01
Male-vs-Female
8.419200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.169600E-01
Normal-vs-Age(41-60Yrs)
3.855000E-01
Normal-vs-Age(61-80Yrs)
5.111000E-01
Normal-vs-Age(81-100Yrs)
1.117960E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.451400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.844600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.683000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.312040E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.139420E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.894400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.629200E-01
Normal-vs-Daily Drinker
3.751000E-01
Normal-vs-Weekly Drinker
4.684000E-01
Normal-vs-Occasional Drinker
5.509400E-01
Normal-vs-Social Drinker
3.927000E-01
Non Drinker-vs-Daily Drinker
2.302400E-01
Non Drinker-vs-Weekly Drinker
9.748000E-01
Non Drinker-vs-Occasional Drinker
2.703800E-01
Non Drinker-vs-Social Drinker
1.556010E-01
Daily Drinker-vs-Weekly Drinker
2.745800E-01
Daily Drinker-vs-Occasional Drinker
8.284400E-02
Daily Drinker-vs-Social Drinker
2.016200E-02
Weekly Drinker-vs-Occasional Drinker
3.032400E-01
Weekly Drinker-vs-Social Drinker
2.337200E-01
Occasional Drinker-vs-Social Drinker
9.333000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.497600E-01
Normal-vs-Grade 2
1.195420E-01
Normal-vs-Grade 3
5.664100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.463600E-01
Grade 1-vs-Grade 3
2.744200E-01
Grade 1-vs-Grade 4
2.497600E-01
Grade 2-vs-Grade 3
8.212400E-01
Grade 2-vs-Grade 4
1.195420E-01
Grade 3-vs-Grade 4
5.664100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.889000E-01
Normal-vs-NonDiabetic
1.291450E-01
Diabetic-vs-NonDiabetic
9.248000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.378600E-01
Normal-vs-NoPancreatitis
1.489390E-01
Pancreatitis-vs-NoPancreatitis
2.359600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.754820E-01
Normal-vs-N1
2.047200E-01
N0-vs-N1
5.962600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.869200E-01
Normal-vs-TP53-NonMutant
5.799400E-01
TP53-Mutant-vs-TP53-NonMutant
4.377600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
